Leuprorelin Acetate

Leuprorelin Acetate is a synthetic gonadotropin-releasing hormone (GnRH) agonist used primarily in the treatment of prostate cancer, breast cancer, endometriosis, and precocious puberty. By reducing the production of sex hormones, it effectively manages hormone-sensitive conditions, helping patients maintain better health outcomes. As a widely utilized therapy, it plays a crucial role in oncology and reproductive health management.